Ad
related to: bristol-myers squibb stock price- Planning for Retirement?
Boost to Your Retirement Plan
The 5 Best Stocks for Retirees
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- Top Hydrogen Stock Plays
5 Hydrogen stocks to buy right now
New report names 5 wealth-builders
- Planning for Retirement?
Search results
Results From The WOW.Com Content Network
With the stock price under pressure, the shares offer an unusually high 4.8% dividend yield. Why Bristol Myers Squibb stock looks like a good investment now.
Bristol Myers Squibb (NYSE: BMY) is a big name in healthcare. And over the years, it has always found ways to grow and expand its business. But this hasn't been a good buy of late. It's not just ...
Shares of Bristol Myers Squibb offer a 5.6% dividend yield at recent prices. After 15 consecutive annual-dividend raises, investors can reasonably rely on this streak continuing in the years ahead.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Bristol Myers Squibb: A high-yield dividend stock with an attractive valuation. Bristol Myers Squibb, or BMS for short, is another well-established pharmaceutical company with a strong presence in ...
In April 2007, The Wall Street Journal reported that "Bristol-Myers Squibb Co. and ImClone Systems Inc. said their cancer drug, Erbitux, failed to significantly prolong the lives of people with pancreatic cancer in a new study, marking yet another setback in the drug industry's efforts to find a better treatment for this deadly disease."
Friday, Bristol Myers Squibb & Co (NYSE:BMY) posted second-quarter revenues of $12.20 billion, beating the consensus of $11.55 billion, an increase of 9% year-over-year, or 11% when adjusted for ...
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day.
Ad
related to: bristol-myers squibb stock price